Study on the Efficacy of LAS41005 Compared to Placebo and to LAS106521 in the Treatment of Actinic Keratosis Grade I to II
Phase of Trial: Phase III
Latest Information Update: 30 Jul 2015
At a glance
- Drugs Fluorouracil/salicylic-acid (Primary) ; LAS 106521
- Indications Actinic keratosis; Skin cancer
- Focus Registrational; Therapeutic Use
- Sponsors Almirall S.A.
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record, EudraCT2007-003889-18).
- 05 Oct 2009 New trial record